Control of cell death is vital for normal physiology, and its altered regulation underlies cancer and other diseases. Commitment to apoptosis is governed by interacting proteins of the Bc1-2 family, which includes both prosurvival members like Bc1-2 and pro-apoptotic ones that either resemble Bcl-2 (e.g. Bax or Bak) or bear only the BH3 interaction domain (eg. Bim). This project explores, by both molecular and genetic approaches, how their interactions and association with mitochondria establish commitment to apoptosis and homeostasis.1) To explore Bim physiological function, our discovery that lymphoid homeostasis requires Bim prompts tests of whether Bim governs the attrition during lymphocyte development (negative and positive selection). 2) To investigate association of Bcl-2 -like proteins with organellar membranes. Binding of Bim to Bc1-2 is proposed to induce a conformational change that augments membrane attachment and ablates survival function.3) To explore whether Bcl-2 docks on mitochondrial pores. Our evidence that Bcl-2 complexes with two pore components will be extended, and its relevance to Bc1-2 localization and survival function assessed.4) To investigate how Bcl-2 and BH3 proteins control activation of Bax-like proteins. The requirement for both Bim and Bax or Bak in lymphocyte apoptosis prompts tests of whether ligation of Bcl-2 by Bim generates a signal that indirectly activates Bax/Bak, or whether certain BH3 proteins can directly activate Bax. Justification: As the proposal addresses central issues about the regulation of apoptosis, builds onproductive research, and exploits novel findings, it should significantly advance the molecular dissection of apoptosis.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA080188-08
Application #
7059307
Study Section
Cell Development and Function Integrated Review Group (CDF)
Program Officer
Mccarthy, Susan A
Project Start
1999-01-01
Project End
2008-03-31
Budget Start
2006-04-07
Budget End
2008-03-31
Support Year
8
Fiscal Year
2006
Total Cost
$164,257
Indirect Cost
Name
Walter and Eliza Hall Institute Medical Research
Department
Type
DUNS #
753236256
City
Victoria
State
Country
Australia
Zip Code
VIC, -3052
Mason, Kylie D; Lin, Ann; Robb, Lorraine et al. (2013) Proapoptotic Bak and Bax guard against fatal systemic and organ-specific autoimmune disease. Proc Natl Acad Sci U S A 110:2599-604
Happo, L; Phipson, B; Smyth, G K et al. (2012) Neither loss of Bik alone, nor combined loss of Bik and Noxa, accelerate murine lymphoma development or render lymphoma cells resistant to DNA damaging drugs. Cell Death Dis 3:e306
Kerr, J B; Brogan, L; Myers, M et al. (2012) The primordial follicle reserve is not renewed after chemical or ?-irradiation mediated depletion. Reproduction 143:469-76
Glaser, Stefan P; Lee, Erinna F; Trounson, Evelyn et al. (2012) Anti-apoptotic Mcl-1 is essential for the development and sustained growth of acute myeloid leukemia. Genes Dev 26:120-5
Kerr, Jeffrey B; Hutt, Karla J; Cook, Michele et al. (2012) Cisplatin-induced primordial follicle oocyte killing and loss of fertility are not prevented by imatinib. Nat Med 18:1170-2; author reply 1172-4
Clybouw, Cyril; Fischer, Silke; Auffredou, Marie Therese et al. (2011) Regulation of memory B-cell survival by the BH3-only protein Puma. Blood 118:4120-8
Wertz, Ingrid E; Kusam, Saritha; Lam, Cynthia et al. (2011) Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7. Nature 471:110-4
Vikstrom, Ingela; Carotta, Sebastian; Lüthje, Katja et al. (2010) Mcl-1 is essential for germinal center formation and B cell memory. Science 330:1095-9
Karlberg, Mats; Ekoff, Maria; Huang, David C S et al. (2010) The BH3-mimetic ABT-737 induces mast cell apoptosis in vitro and in vivo: potential for therapeutics. J Immunol 185:2555-62
Kvansakul, Marc; Wei, Andrew H; Fletcher, Jamie I et al. (2010) Structural basis for apoptosis inhibition by Epstein-Barr virus BHRF1. PLoS Pathog 6:e1001236

Showing the most recent 10 out of 103 publications